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Summary 
Overexpression of the RHAMM gene by transfection 
into fibroblasts is transforming and causes spontane- 
ous metastases in the lung. H-ras-transformed fibro- 
sarcomas transfected with a dominant suppressor mu- 
tant of RHAMM exhibit a so-called revertant phenotype 
and are completely nontumoriqenic and nonmetastatic. 
Conversely, fibroblasts stably expressing low levels 
of RHAYY as a result of antisense transfection are 
resistant to ras transformation. Collectively, these re- 
sults indicate that RHAMM acts downstream of ras. 
The loss of functional RHAMY ablates signaling within 
focal adhesions, In particular changes in focal adhe- 
sion kinase phosphorylation, and as a result these fo- 
cal adhesions are unable to turn over in response to 
hyaluronan. These results provide evidence of the on- 
coqenic potential of a novel extracellular matrix recep 
tor and establish a functional link between transforma- 
tion by ras and signaling within focal adhesions that 
are required for transformation by this oncoqene. 
Introduction 
Extracellular matrix(ECM) molecules, their receptors, and 
gene products that modify the ECM are able to influence 
directly cell characteristics such as growth and motility 
(Ratner, 1992; Damsky and Werb, 1992; Hynes, 1992; 
Ruoslahti et al., 1994; Lin and Bissell, 1993; Jones et al., 
1993), to regulate cellular responses to growth factors and 
cytokines (Noble et al., 1993; Chong et al., 1992; Hiro et 
al., 1988) and to modify the transformed state. Many of 
these ECM receptors and their ligands can regulate the 
invasivelmetastatic phenotype in tumorigenic cells. Thus, 
overexpression of a481 integrin inhibits invasion during 
metastasis (Qian et al., 1994) while overexpression of 
the urokinase receptor enhances invasion (Kariko et al., 
1993). A regulator of metalloproteinases, TIMP-1, inhibits 
invasion of metastatic cells (Khokha et al., 1992; Alexan- 
der and Werb, 1992). Other ECM receptors, however, par- 
tially modify the transformed state of cells. Thus, a581 
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integrins partially restore contact inhibition and anchor- 
age-dependent growth properties of the tumorigenic CHO 
cells (Giancotti and Ruoslahti, 1990), while overexpres- 
sion of thrombospondin (Castle et al., 1993) results in the 
development of serum-independent growth. However, 
none of these ECM receptors has been frankly shown to 
be transforming. 
The receptor for hyaluronan-mediated motility (RHAMM) 
signals elevated cell locomotion via a transient tyrosine 
phosphorylation within focal adhesions that results in their 
turnover in ras-transformed cells (Hall et al., 1994). RHAMM 
is regulated by growth factors such as transforming growth 
factor pl (TGFPl), and its expression is necessary for 
TGF81 stimulation of fibrosarcoma cell motility (Samuel 
et al., 1993). We show here that, in contrast with other 
ECM receptors, overexpression of the hyaluronan (HA) 
receptor RHAMM (Hardwick et al., 1992) is both trans- 
forming and able to generate a metastatic phenotype, in 
which the subcutaneous tumors of RHAMM-transfected 
cells spontaneously metastasize, and these cells also form 
lung colonies after inoculation in the tail vein. The ability 
of RHAMM to transform fibroblasts indicates that this re- 
ceptor functions in a fundamentally different manner than 
other characterized ECM receptors. In view of the elevated 
expression of RHAMM in r&s-transformed cells (Turley et 
al., 1991) and its importance in the locomotion of these 
cells (Hardwick et al., 1992), we have also investigated 
the role of this receptor in ras transformation. We show 
here that disruption of RHAMM function by antisense RNA 
expression or by a dominant negative mutant of RHAMM 
profoundly reduces the transforming properties of the ras 
oncogene. We also link the ability of the dominant negative 
RHAMM mutation to ablate ras transformation to an effect 
on signaling via the focal adhesion kinase (FAK), ppl 25FAK, 
within focal adhesions. 
Results 
Overexpression of RHAMM in Fibroblasts 
induces Transformation 
Since it had been previously shown that RHAMM expres- 
sion was elevated in ras-transformed cells (Turley et al., 
1991; Hardwick et al., 1992; Samuel et al., 1993) the con- 
tribution of RHAMM to the transformation process was 
investigated by its overexpression in nonsenescing fibro- 
blasts. lOTl/z fibroblasts were transfected with either a 
genomic RHAMM clone, M (Hardwick et al., 1992; Entwis- 
tle et al., 1995) or a RHAMM cDNA encoding an isoform 
common to ms-transformed cells (RHAMM 1~4, Zhang et 
al., submitted). Both transfections were chemically se- 
lected, and cell lines were cloned. Five clones that overex- 
pressed RHAMM, as determined by Western blot analysis 
of cell lysates (Table 1) and Northern blot analysis of 
RHAMM RNA (data not shown), were selected from each 
transfection. These selected clones were further charac- 
terized, and their properties are summarized in Table 1. 
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Table 1. Characteristics of RHAMM-Transfected lOT% Clones 
Densi- Rate of Motility 
tometry FACS’ (uM/hr * SEM) 
Of Mean 
RHAMM Fluores- Subcuta- 
Western cent Anti- Nuclear neous Sponta- 
Blot lnten- RHAMM Foci per Overlap Tumors neous 
Cell Line Analysis sky Control Antibody Dish Rate in Mice Metastases 
lOTY2 fibroblast 0.31 2.4 10.0 f 0.84 8.8 f 1.2 13 f 4 0.01 0 of 4 0 of 8 
C3 fibrosarcoma 1.35 85.0 35.1 f 2.2 10.2 f 1.4 77 f 9 0.45 4 of 4 ND 
Genomic RHAMM transfectants 
Vector only 0.54 2.5 10.6 f 0.9 9.9 f 0.4 12 f 3 0.02 0 of 4 0 of 8 
14-2-l OTH 1.29 82.5 36.6 f 4.4 ND ND 0.36 ND ND 
14-6-l OTM 2.20 43.0 31.8 f 2.0 ND ND 0.25 ND ND 
M-l O-l OT’/z 1.08 74.8 25.6 e 1.7 10.9 f 1.7 150 + 7 0.49 4 of 4 ND 
M-1 2-l OT’/z 2.77 116.0 36.1 f 2.2 11.7 * 0.5 249 f 16 0.42 4 of 4 4 of 8Q 
RHAMM cDNA transfectants 
Vector only 0.35 3.9 9.8 -c 0.5 9.8 11 f 4 0.01 Oof4 ND 
cDNA 5-l OTM 2.65 74.8 24.5 f 2.3 10.1 f 2.1 240 f 10 0.41 4 of 4 ND 
cDNA-3T3 ND ND ND ND 25OztlO ND 4 of 4 ND 
MR-lOTW-4 1.56 81.3 11.1 f 0.6 9.3It1.2 0 0.01 Oof4 ND 
lOT% cells were transfected with genomic RHAMM (14) for clones 2.6, IO, and 12, RHAMM cDNA (RHAMM 1~4; Entwistle et al., 1995) for clone 
cDNA 5-lOT*/z or RHAMM cDNA mutated in its HA-binding domains for clone MR-IOT%4. NIH 3T3 cells were transfected with RHAMM cDNA 
(RHAMM 1~4) for clone cDNA-3T3. Characteristics were determined as outlined in Experimental Procedures. Motility rate was obtained by tracking 
100 cells. ND, not determined. 
LI Corrected for background fluorescence in the presence of normal IgG. 
b Mean of five colonies per lung. 
Cells transfected with the RHAMM gene overexpressed 
a 73 kDa protein consistent with the predicted size of 
RHAMM (data not shown; Entwistle et al., 1995). The same 
cells displayed an increase in a 4.2 kb message, the size 
of the major RHAMM mRNA transcript (data not shown; 
Hardwick et al., 1992). The presence of the transfected 
RHAMM gene in all clones was confirmed by polymerase 
chain reaction (PCR) detection of plasmid arms (data not 
shown). The selected clones overexpressed products of 
the RHAMM gene at the cell surface as determined by 
fluorescence-activated cell sorter (FACS) analysis (Table 
1). Transfected cells appeared morphologically trans- 
formed (in that they were rounded), showed no evidence 
of contact inhibition, and possessed few focal adhesions 
(data not shown). Moreover, they exhibited a high nuclear 
overlap index comparable with that of ras-transformed 
cells (Table 1) and formed foci in monolayer culture, unlike 
the vector controls or the lOT% parent cell line (Table 1). 
Furthermore, transfected cells reached culture confluence 
at a 3-fold to dfold higher ceil number relative to vector 
control or parent line controls (data not shown). The rate 
of random locomotion of the transfected cells was P-fold 
to 3-fold higher than control cell lines, a rate comparable 
with the ras-transformed C3 cell line (Table 1). This high 
motility was maintained at subconfluence and was blocked 
by anti-RHAMM antibodies (Table 1). The rate of growth 
of RHAMM-transfected cell lines was less than that of ras- 
transformed C3 cells and was, in fact, identical to that of 
the control cells until confluence halted growth of the latter. 
Nevertheless, RHAMM-transfected cells grew in an 
anchorage-independent fashion in soft agar (data not 
shown). Similar results on cell behavior were obtained 
after transfection of the RHAMM lv4 cDNA in a pHj3 
APr-1-neo vector into lOTV2 or 3T3 fibroblasts (Table 1). 
Transfection of RHAMM lv4 cDNA containing mutated 
HA-binding domains (Figure 1) had no effect on morphol- 
ogy, contact inhibition, or motility (Table 1). 
To determine whether cells transfected with the 
RHAMM X4 gene were tumorigenic, we subcutaneously 
injected 1 x IV to 5 x 1 OB cells into the right hind leg 
of syngeneic mice. Fibrosarcomas formed within 3 weeks; 
no tumors formed in mice injected with vector-transfected 
or lOT% parental control cells (Table 1). Tumors derived 
from the transfected cells were identical histologically to 
those formed byras-transformed cells and expressed high 
levels of RHAMM, as seen immunohistochemically. Fur- 
ther, in approximately 50% of animals bearing subcutane- 
ous tumors, tumors spontaneously metastasized to the 
lung to form a mean of five nodules per lung (Table 1). 
The occurrence of tumor cells within these nodules was 
confirmed by histology. Cells injected into mice via the tail 
vein invaded lung tissue and formed metastatic nodules 
(Table 1). Cells transfected with RHAMM lv4 cDNA were 
also tumorigenic and metastatic, but cells expressing the 
mutated RHAMM 1~4, lacking HA-binding domains, were 
not (Table 1). 
These results were repeated with NIH 3T3 fibroblast cell 
line. We subcutaneously inoculated 5 x 10s transfected 
cells into syngeneic mice, and the presence of tumors was 
observed by 3 weeks (Table 1). 
Reversion of H-ras Transformation with a Dominant 
Suppressor Mutant of RHAMM 
The importance of RHAMM for maintenance of the trans- 
formed phenotype of H-fas-transformed fibrosarcomas 
was examined by blockade of RHAMM function with a 
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Figure 1. Reversion of H-fas-Transformed C3 
Fibrosarcomas by Expression of RHAMM Mu- 
tated in Its HA-Binding Domain 
(A) Strategy for mutating the HA-binding do- 
mains (boxed) of RHAMM. Lysines (K) and argi- 
nines (R) were altered as indicated, and this 
alteration has been shown to destroy the HA- 
binding properties of the RHAMM protein 
(Yang et al., 1994). RHAMM fusion protein was 
prepared from the intact cDNA (designated 
RHAMM fusion protein), electrophoresed, and 
assayed for biotinylated HA binding in a 
transblot assay. Fusion protein was produced 
from the RHAMM cDNA, which was mutated 
as described in Experimental Procedures, Mu- 
tated RHAMM fusion protein did not bind HA. 
(B) C3 cell lysates were prepared from cells 
that were transfected with vector control (lanes 
1 and 5) or mutated RHAMM cDNA (lanes 2-4 
and 6-6, which represent clones MR-C3-4D, 
MR-C3-58, and MR-C3-SC) and were electro- 
phoresed and analysed for RHAMM using a 
Western transblot analysis (lanes l-4). The 
blot was then stripped and reprobed with biotin- 
ylated HA (lanes 5-8). RHAMM was overex- 
pressed in the transfected cell lines, but 
RHAMM from these cells bound less HA than 
controls, consistent with a dominant negative 
action by the mutated protein. 
(C) Total RHAMM expression on the cell membrane assessed by FACS analysis revealed major increases in MR-C3 clones relative to the vector 
control. 
(D) Cell lysates were obtained from C3 vector controls (lane I), lOT% fibroblasts (lane 2) and the three MR-C3 clones, MR-C3-4D, MR-C3-5B, 
and MR-C3-5C (lanes 3-5, respectively) and electrophoresed; ~21~~ was then visualized in a Western transblot analysis using a pan-specific 
anti-Ras antibody. All of the MR-CS-transfected clones expressed high levels of p21ms, comparable with C3 (lane 1). 
RHAMM cDNA mutated at it8 HA-binding domains (Figure 
1). Similar suppressor mutations have been previously 
prepared by mutating the kinase domain (Evans et al., 
1993) or by deleting the cytoplasmic domains of other re- 
ceptors (Kashles et al., 1991). The present approach to 
functional ablation was taken because RHAMM is se- 
creted, is localized at the cell surface, and forms homodi- 
mers (Hardwick et al., 1992; Klewes et al., 1993). Further- 
more, mutation of the HA-binding domains in RHAMM 
destroys its ability to transform fibroblasts morphologically 
(Table 1). Collectively, these conditions have been found 
to be sufficient to cdnstruct suppressor mutations of such 
growth-factor receptors as TGFPl (Brand et al., 1993). The 
details of the amino acid substitutions in the HA-binding 
domains of RHAMM are outlined in Figure 1A. Loss of HA 
binding was confirmed using the mutated RHAMM fusion 
protein in a ligand blotting assay, the specificity of which 
has previously been demonstrated (Figure 1A; Hoare et 
al., 1993). ras-transformed lOT% fibroblasts (termed C3) 
were transfected with the mutated RHAMM and chemi- 
cally selected in hygromycin. Over 20 clones were se- 
lected, 25% of which displayed a flattened cell shape that 
was morphologically similar to 10TVz fibroblasts not trans- 
formed by ras (Figure 2C). Three clones containing the 
mutated RHAMM protein were selected for further analy- 
sis, and all three were found to overexpress RHAMM by 
2.fold to 3-fold, as determined by Western blot analysis 
(for examples see Figure 1 B, lanes 2-4). Increased cell- 
surface expression of RHAMM was detected by FACS 
analysis (see Figure 1 D) using antibody A268 (Hardwick 
et al., 1992) which specifically recognizes a peptide en- 
coded in the RHAMM cDNA (amino acids 268-289) that 
is 5’ to the mutated region of the protein (see Figure 1C). 
Despite their flattened morphology, all clones overex- 
pressing mutant RHAMM exhibited levels of ~21”” protein 
that were comparable with or higher than those seen in 
the H-ras-transformed C3 fibrosarcoma cells transfected 
with vector only (see Figure 1 C). 
Despite the expression of high levels of activated ras, 
clones expressing the suppressor mutant of RHAMM (MR- 
C3-4D, MR-C3-58, and MR-C3-5C) more closely resem- 
bled the nontransformed lOT% cells in their growth char- 
acteristics, locomotion rates, and tumorigenic capabilities. 
Mutated RHAMM clones were contact inhibited and dis- 
played a low nuclear overlap ratio, comparable with that 
of the nontransformed lOTlIz cell line (Figures 2A-2C). 
They had a lower saturation density than ras-transformed 
vector control cells (Figure 2D) and showed suppressed 
ratesof locomotion in comparison with transformed paren- 
tal C3 fibrosarcoma cell8 (Table 2). In contrast with vector- 
transfected controls, the cells expressing the dominant 
suppressor RHAMM failed to form foci in monolayer cul- 
tures (Figure 2E) and did not form colonies in soft agar 
(Table 2). When injected subcutaneously into syngeneic 
mice, no tumors were detected after 6 months of observa- 
tion (Figure 2F), while vector controls and the ras-lOT% 
parent cell line formed large tumors within 3 weeks (Figure 
2F). In addition, the clones expressing mutated RHAMM 
did not develop tumors in the lung colonization assay for 
metastasis (Figure 2G). 
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Figure 2. Morphological and Growth Properties of Dominant Negative 
Mutant Transfected C3 Cells 
(A-C) Cell morphology of transfected cell lines including 1OTVz parent 
line (A), vector-transfected C3 cells (B), and MR-C3-transfected cells 
(C). The MR-C3 cells resemble the nontransformed IOTVz line, ap- 
pearing flattened and contact inhibited in contrast with the vector- 
transfected ras-transformed parent C3 line. 
(D) Growth curve of vector control-transfected C3 cells (open circles) 
and MRC33D (closed diamond), MR-C3-5B (closed square), and MR- 
C3-5C (closed circle) clones. We plated 5 x 10’ cells, and the number 
of cells was counted each day with a Coulter counter. The vector 
control-transfected cells grow more rapidly than the mutant RHAMM- 
transfected ras-transformed cells and reach a much higher saturation 
density. 
(E) A focus-forming assay was performed as described in Experimental 
Procedures using vector control-transfected C3 cells and MRC3-4D 
clone. The vector controls formed multiple foci in dense culture, while 
the cells transfected with mutated RHAMM did not form foci. 
(F) Mice injected with either C3 parent line (1) or vector control (2) 
formed large fibrosarcomas (arrows) by 3 weeks after injection. Mice 
injected with MRC3-4D (3) or MR-C35C (4) clones did not form tumors 
after 6 months of observation. 
(G) The vector control C3 control injected into the tail vein of mice 
formed multiple lung colonies in the mouse (top). None of the three 
MR-CS clones (MR-C3-4D, MR-C3-5B, and MRC35C) formed detect- 
able colonies (bottom). 
Expression of Dominant Suppressor RHAMM 
Ablates Signal Transduction 
to Focal Adhesions 
We have previously shown that in ras-transformed fibro- 
blasts RHAMM signals cell locomotion via a transient tyro- 
sine phosphorylation pathway that targets focal adhesions 
(Hall et al., 1994). Stimulation of these cells results in two 
rapid and transient events: tyrosine phosphorylation of 
several protein bands and the formation of focal adhe- 
sions. Net dephosphorylation and focal adhesion turnover 
rapidly follow concomitant with elevated cell motility. Since 
expression of the dominant suppressor RHAMM inhibits 
cell locomotion, among other transformationdependent 
processes (Table 2) we examined the effect of this protein 
on signal transduction and focal adhesions. Vector-trans- 
fected C3 cells responded to HA stimulation as previously 
reported (Hall et al., 1994), with a transient increase in 
the phosphorylation of several protein bands (~185, ~125, 
~115, and p85), followed by net dephosphorylation (Figure 
3A). In particular, ~~125~~~ has been identified as a sub- 
strate in this pathway (Hall et al., 1994). Transient tyrosine 
phosphorylation of this substrate, followed by dephos- 
phorylation, coincidental with focal adhesion turnover, is 
observed in vector control cells (Figure 38). Tyrosine phos- 
phorylation of FAK and other protein bands in the domi- 
nant suppressor-expressing cells (MR-C3-4D) remained 
constant over the stimulation time course (Figures 3A and 
38). Thus, ras-transformed fibroblasts expressing the 
dominant suppressor RHAMM cannot utilize the signal 
transduction pathway that involves changes in FAK phos- 
phorylation and that is required for transformation by ras. 
Cells possessing stable focal adhesions move more 
slowiy and are less tumorigenic (see Discussion). fas- 
transformed fibroblasts normally have very few focal adhe- 
sions, but form temporary focal adhesions at the cell edge 
after HA stimulation (vector control, Figure 3Ca). On the 
contrary, the cells expressing the HA binding-deficient 
RHAMM have numerous focal adhesions throughout the 
cell in the presence or absence of HA (Figure 3Cb), thus 
resembling nontransformed lOTI/ fibroblasts. Similarly, 
tyrosine phosphotylation levels in these cells are higher 
and largely occur in the focal adhesions (Figure 3Cd). The 
HA-stimulated vector control cells exhibit rapid onset of 
increased phosphotyrosine staining only at the lamellae 
edges and only at 1 min after stimulation with HA, while 
Table 2. Suocression of Transformation by Expression of RHAMM Mutated in Its HA-Binding Domain 
Growth in Soft Agar Nuclear Overlap Rate of Motility 
Cell Line (Colonies f SEM) Ratio Foci per Dish (pM/hr f SEM) 
1 OT’/z 0 0.01 0 9.5 f 1.3 
C3 vector control 77 f 9 0.47 >60 27.5 f 1.2 
MRC3-4D 0 0.005 0 3.5 f 0.6 
MR-C3-58 If1 0.004 0 1.9 f 0.5 
MRC35C 0 0.005 0 2.0 -c 0.6 
The H-ras-transformed C3 fibrosarcoma was transfected either with vector control (C3 vector control) or with RHAMM (Entwistle et al., 1995) 
mutated in its HA-binding domain (MRXX-tD, MR-C35B, MR-C3-5C), while lOT% is the nontransformed parental line of the C3. 
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Figure 3. Overexpression of Dominant Suppressor RHAMM Prevents 
Tyrosine Phosphorylation, Focal Adhesion Kinase Dephosphorylation, 
and Focal Adhesion Turnover in ras-Transformed Fibroblasts 
(A) Cultures (24 hr) of vector control C3 fibroblasts (left) and MR-C3-4D 
(right) were stimulated with HA (10 @ml) for 0 min (lane I), 1 min 
(lane 2), 5 min (lane 3), or 15 min (lane 4) prior to cell lysis. Equal 
protein concentrations from each sample were run on SDS-polyacryl- 
amide gels, transferred to nitrocellulose, and subjected to anti-phos- 
photyrosine immunoblot analysis. Vector control cells displayed a 
rapid and transient increase in the tyrosine phosphorylation of ~165, 
~125, ~115, and p65 (arrows), followed by a decrease in the phosphory- 
lation of these protein bands, as did the ras-lOT% C3 fibroblasts (data 
not shown). The level of tyrosine phosphorylation in the MR-C3-4D 
cells did not change with HA treatment. Similar results were obtained 
with the clone MR-C3-%C (data not shown). The molecular markers 
(M) indicate 160, 125,66, and 65 kDa. 
(6) Cell cultures of vector control C3 fibroblasts and mutated RHAMM- 
overexpressers MR-CZUD were stimulated as described above for 1 
min (lanes 2 and 5) or 15 min (lanes 3 and 6) with HA or with buffer 
alone (lanes 1 and 4) and then were lysed in RIPA buffer. Immunopre- 
cipitation was performed with anti-FAK (lanes l-6) or mouse IgG con- 
trol (lane 7), followed by SDS-polyacrylamide gel electrophoresis and 
anti-phosphotyrosine immunoblot analysis. Vector control fibroblasts 
(lanes 1-3) exhibit an increase followed by a decrease in FAK phos- 
phorylation. The MRC34D cells (lanes 4-6) show no change in FAK 
phosphorylation with HA treatment. 
(C) lmmunofluorescent localization of vinculin and phosphotyrosine 
in vector control C3 and MR-C3-4D fibroblasts before and after HA 
treatment. Fibroblasts were incubated in the absence (0) or presence 
of 10 rig/ml HA for 1 min (1 and IgG) or 15 min (15) before fixation 
and staining with anti-vinculin (a and b) and anti-phosphotyrosine (c 
and d). Mouse IgG control panels are shown (bottom row). Vector 
control cells (a and c) exposed to HA for 1 min show an increase in 
both focal adhesions (anti-vinculin) and anti-phosphotyrosine staining, 
which then decreases by 15 min of treatment. MR-C3-4D (b and d) 
and MR-C3-5C (data not shown) display focal adhesions and phospho- 
tyrosine staining that do not change with treatment. 
the MR-C3-4D cells do not respond to HA, but maintain 
high levels of plaque-like phosphotyrosine staining in the 
cell body and at the lamellae edges (Figure 3Cc and 3Cd). 
Antisense RHAMM Confers Resistance 
to Transformation by Mutant H-MS 
To determine whether fibroblasts with suppressed RHAMM 
expression could be transformed with ras, we transfected 
lOT% cells with RHAMM cDNA in an antisense orienta- 
tion. Two G418 resistant clones (termed OR1 and OR2) 
that expressed 100/o-50% of the detectable RHAMM pro- 
tein levels seen in vector controls were selected from over 
60 clones with varying reductions of RHAMM expression 
(X. Y. et al., unpublished data). The twoclones expressing 
low levelsof RHAMM protein were identical in their proper- 
ties. The presence of RHAMM antisense and the reduction 
or lack of RHAMM message was demonstrated by reverse 
transcription-PCR (RT-PCR) and confirmed by Southern 
blot hybridization (X. Y. et al., unpublished data). The two 
transfected cell lines, the vector control, and the parent 
1 OT% cells were then grown to confluence and transfected 
with an activated H-ras. The vector control and the paren- 
tal line formed multiple large and small foci after 3 weeks 
in culture (Figures 4A-4B), whereas cultures containing 
the OR1 and OR2 constructs formed no such foci (Figures 
C 
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Figure 4. Inhibition of Transformation by Mutant H-ras in Fibtoblasts 
Expressing Antisense RHAMM Clones OR1 and OR2 
1OTM parent cells transfected with fas (A), vector control lOT% cells 
transfected with ras (B), OR1 clone transfected with ras (C), and OR2 
clone transfected with ras (D). rss vector exhibited multiple large foci 
formed in controls, but clones transfected with RHAMM antisense did 
not form foci. (E) Ras protein is expressed in ras-transfected OR1 and 
OR2 fibroblasts. All cells transfected with rss (lane 1, ras-transformed 
C3celis; lane2, antisensevector, only lOT% clone 1; lane3, antisense 
vector, only lOT% clone 2; lane 4, OR1 cells; lane 5, OR2 cells) ex- 
pressed ~21”~ protein, as detected in a Western blot assay with a 
pan-rss antibody. Levels of expression (lanes 2-5) are approximately 
equivalent and are higher than normally expressed in parental lOT% 
cells (see Figure 2D). 
4C-4D). Furthermore, these clones, unlike ras-trans- 
formed controls, retained a flattened morphology. All ras- 
transfected cultures expressed p21m* protein (Figure 4E) 
at levels similar to those of the ras-transformed cell line 
C3 (compare Figure 4E with Figure 1C). 
Discussion 
We demonstrate here that the HA receptor RHAMM, a 
GPI-linked plasma membrane protein (L. Klewes et al., 
unpublished data), is not only transforming, but that its 
expression is sufficient to generate a metastatic fibrosar- 
coma. In addition, RHAMM also appears to be necessary 
for initiating and maintaining transformation induced by 
other oncogenes, such asras. Since ras-transformed cells 
expressing nonfunctional RHAMM are unable to signal 
and turn over focal adhesions, these results also imply a 
direct role for RHAMM in signaling within these cytoskele- 
tal structures in the transformation process downstream 
of ras. 
The transforming capability of RHAMM and the inability 
of RHAMM mutated in its HA-binding domains to transform 
cells demonstrate a causal role for HA in the transforma- 
tion process. The observation that mutation of RHAMM 
in its HA-binding domains ablates fas transformation pro- 
vides further evidence connecting HA to transformation. 
HA, a ubiquitous glycosaminoglycan, has previously been 
linked with both transformation and the metastatic process 
(Turley, 1992; Knudson and Knudson, 1993; Fraser and 
Laurent, 1993), since it is often enriched in tumor-associ- 
ated stroma (Turley and Tretiak, 1984) and its presence 
facilitates melanoma invasion across chorioallantoic 
membranes (Turley et al., 1987). Highly metastatic tumor 
cells produce more HA (for review see Knudson and Knud- 
son, 1993) and express higher levels of HA receptors 
(Gtinthert, 1993; Hynes, 1992; Hardwicket al., 1992) than 
less metastatic counterparts. Moreover, overexpression 
of one of the isoforms of the HA receptor CD44 increases 
primary and secondary tumor growth (Sy et al., 1991) 
a property that requires the HA-binding domain of this 
receptor (Bartolazzi et al., 1994). As well, the V6 isoform 
of CD44 bestows a metastatic phenotype on transformed 
cells (Giinthert et al., 1991), although it is not known 
whether this property is dependent upon the HA-binding 
capability of this &form. 
As noted in the introduction, other ECM receptors and 
ECM molecules (Hynes, 1992; Gtinthert et al., 1991; 
Stetler-Stevenson et al., 1993; Schwartz, 1993; Behrend 
et al., 1994) have also been linked to the regulation of the 
invasive properties of cells or to the partial modification 
of the transformation process itself. It is important to note, 
however, that none of these molecules has been demon- 
strated to be transforming by itself, implying that RHAMM 
has a unique role in orchestrating events that are essential 
for transformation to occur. These events include the abil- 
ity of RHAMM to signal, via focal adhesions, alterations 
in the cytoskeleton and elevated cell locomotion. 
Focal adhesions are sites of ECM receptor-cytoskeletal 
interactions, where second-messenger signaling com- 
monly occurs in response to the ECM and some growth 
factor receptors. These structures, also described as sig- 
nal transduction units (Lo and Chen, 1994; Zachary and 
Rozengurt, 1992) are believed to be critical for the regula- 
tion of growth and cell motility (Woods and Couchman, 
1988; Burridge et al., 1988). They have previously been 
linked to transformation, in that very few focal adhesions 
are present in tumor cells (Burridge et al., 1988) and focal 
adhesion assembly promoted by overexpression of the 
focal adhesion components, a581 integrin, tensin, or vin- 
culin, causes partial reversal of transformation (Giancotti 
and Ruoslahti, 1998; Varner et al., 1992; Lo and Chen, 
1994). Conversely, antisense ablated expression of the 
focal adhesion protein vinculin promotes transformation- 
dependent properties (Rodriguez-Fernandez et al., 1993); 
as well, the selective targeting of truncated v-src to focal 
adhesions, but not to the nucleus or to the cytoplasm, is 
sufficient for transformation by this oncogene (Leibl and 
Martin, 1992). We have previously noted that in ras- 
transformed fibroblasts, unlike their parental counter- 
parts, HA regulates cell motility via RHAMM by signaling 
transient protein-tyrosine phosphorylation within focal ad- 
hesions (Hall et al., 1994). In this signaling pathway, FAK 
is transiently phosphorylated, followed by net dephosphor- 
ylation and focal adhesion turnover leading to the initiation 
of cell locomotion (Hall et al., 1994). Cells overexpressing 
RHAMM resemble ras-transformed fibroblasts and have 
elevated cell locomotion and focal adhesion loss, as well 
as tumorigenic and metastatic potential. Conversely, ex- 
pression of a dominant suppressor mutant of RHAMM re- 
verts transformation induced by fas and stabilizes focal 
adhesions (X. Y. et al., unpublished data). This HA recep- 
tor targets focal adhesions and likely acts downstream of 
ras or via a parallel pathway that converges at the level 
of ras. 
FAK has been implicated in several signaling pathways 
that involve ECM receptors, as well as in transformation 
(Schaller et al., 1992; Calalb et al., 1994). The stimulation 
of activation by growth factors, neuropeptides, and the 
ECM is associated with cell attachment, focal adhesion 
assembly, and stress fiber formation (Schaller and Par- 
sons, 1994; Zachary and Rozengurt, 1992). Cell adhesion 
via in&grins can stimulate the formation of signaling com- 
plexes containing FAK, c-src, Grb-2, and Sos (Schlaepfer 
et al., 1994) thus providing a mechanism for the regulation 
of the ras/MAP kinase signaling cascade downstream of 
FAK phosphorylation. On the contrary, transient FAK 
phosphorylation, followed by net FAK dephosphorylation, 
has been associated with elevated cell migration (Hall et 
al., 1994; Matsumoto et al., 1994) and, hence, may repre- 
sent the mechanism by which ras and RHAMM regulate 
elevated cell motility. We show here that a dominant sup- 
pressor mutation of RHAMM that ablates ras transforma- 
tion collectively prevents HA binding, HA-triggered FAK 
signaling, focal adhesion turnover, and cell motility. Thus, 
while integrin and growth factor-regulated FAK phosphor- 
ylation would appear to be upstream of ras signaling, our 
results indicate that FAK dephosphorylation, regulated by 
RHAMM, acts downstream of mutant ras and is an event 
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that is required for transformation by this oncogene. While 
our results specifically suggest that the constitutive ability 
to turn over focal adhesions is a requirement for ras trans- 
formation, this event by itself is unlikely to be sufficient 
for transformation to occur. Hence, the overexpression of 
either of the ECM components, thrombospondin or tenas- 
tin, reduces focal adhesion assembly (Borsi et al., 1992; 
Murphy-Ullrich and Hook, 1989), but both are only partially 
transforming, merely enhancing serum- and anchorage- 
independent growth of immortalized cell lines (Castle et 
al., 1993; Murphy-Ullrich et al., 1991; Wehrle-Haller and 
Chiquet, 1993). Also, loss of focal adhesions induced by 
the overexpression of a truncated rasGAP has little effect 
on growth potential (McGlade et al., 1993). The regulation 
of focal adhesion turnover, probably effected by dephos- 
phorylation of FAK, is likely required for transformation 
to occur, but is unlikely to account for !he tumorigenicl 
metastatic properties. Thus, overexpression of RHAMM 
must result in transformation by altering additional cell 
characteristics. 
Signaling via tyrosine phosphorylation has previously 
been identified as an event that can lead to transformation, 
and since RHAMM transiently activates protein phosphor- 
ylation, such signaling may ultimately lead not only to focal 
adhesion turnover, but also to selective expression of 
genes that act collectively through ras to transform the 
cell. Previous reports link signal transduction pathways 
mediated by other ECM receptors (Damsky and Werb, 
1992; Hynes, 1992; Juliano and Haskill, 1993; Schwartz, 
1993) to changes in gene expression (Jones et al., 1993). 
Mammary epithelial cells produce tissue-specific proteins 
in response to basement membranes(Howlett and Bissell, 
1993), while laminin, fibronectin, and other ECM compo- 
nents regulate stromelysin, collagenase (Werb et al., 
1989; Shapiro et al., 1993; Saarialho-Kere et al., 1993), 
and other genes (Jones et al., 1993). HA has also pre- 
viously been reported to regulate the expression of several 
cytokinegenes, in partviaCD44(Nobleet al., 1993; Chong 
et al., 1992). It is likely therefore that other genes are also 
regulated by RHAMM. 
Insummary, wahavedemonstrated thatoverexpression 
of RHAMM is transforming and that ablation of RHAMM 
expression or its function prevents ras transformation. We 
also provide direct evidence of a role for signaling within 
focal adhesions for maintaining ras transformation. 
Experimental Procedures 
Cell Culture and Cell Lines 
The previously established murine fibroblast cell lines lOT%, NIH 3T3, 
and the H-ras-lOT1/?: CIRAS-3 (C3; Egan et al., 1987) were utilized 
for the various transfection and tumorigenic studies. The cells were 
maintained at 37OC in 5% CO* in DMEM growth media (GIBCO BRL) 
supplemented with 10% fetal calf serum (Invitrogen). Cells were sub- 
cultured using trypsin and EDTA (0.25% Difco bactottypsin, 2 mM 
EDTA) prior to reaching confluence. To determine culture density, we 
added 5 x lOa cells to each of 24 wells in 1 ml of DMEM supplemented 
with 10% FCS and 0.6 mg/ml geneticin. Medium was changed every 
3 days, and at each timepoint cells were released from the substratum 
with 0.25% trypsin and counted with a Coulter counter. 
Preparation of DNA Constructs 
The full-length RHAMM gene was isolated from a 3T3 cell genomic 
library and is describedelsewhere (Enhvistleet al., 1995). Thegenomic 
RHAMM clone 14 was harbored in EMBWphage armsfortransfection. 
RHAMM cDNAs, mutated cDNAs, and antisense cDNAs (Hardwick et 
al., 1992; Entwistle et al., 1995) were cloned into the pHP APr-1-neo 
expression vector (Gunning et al., 1987). The cDNAs mutated in their 
HA-binding domains have been described previously (Yang et al., 
1994). In brief, mutagenesis of specific basic amino acids in both of 
the HA-binding domains of RHAMM was accomplished in two steps. 
First, site-directed mutations were confined to basic amino acids Lys- 
405 and Lys-409. Next, the basic amino acids 430 and 432 were mu- 
tated using the RHAMM cDNA generated in the first step. The muta- 
tions abolish HA binding of the resulting protein (Figure 1; Yang et 
al., 1994). The RHAMM antisense cDNA was produced by PCR of the 
entire coding region (amino acids l-477; Hardwick et al., 1992) and 
172 ntof the S’flanking sequence. The fragment cloned into the expres- 
sion vector in the antisense orientation was sequenced for confir- 
mation. 
Transfection with Genomic RHAMM In RHAMM cDNAs 
The RHAMM M clone in EMBW phage arms was cotransfected with 
PSV, plasmid into lOT% fibroblasts using calcium phosphate. 
RHAMM-transfected cells were selectively grown in growth media con- 
taining 0.6 mglmlG418 for 3 weeks, colonies were cloned by selective 
trypsinization, and 15 clones were isolated. Four clones (14-2-lOTl/z, 
X4-6-lOTM, 14-lo-IOTX?, and 14-12-lOTl/z) that exhibited stable in- 
tegration of the RHAMM gene by Southern blot analysis and overex- 
pression of the RHAMM protein by immunoblot analysis were selected 
for further study. 
lOT’/z and NIH 3T3 cell lines were transfected with either the 
RHAMM Iv4cDNA construct (Entwistle et al., 1995; S. 2. et al., unpub- 
lished data) in the pHp Apr-I-neo expression vector (Gunning et al., 
1987)orthe RHAMM lv4cDNAmutatedconstructasdescribedabove. 
To produce stably transfected cell lines, we transfected fibroblasts 
using lipofectin (GIBCO BRL) according to the instructionsof the manu- 
facturer, and cells were selected in G418. Clones were then selected 
as above and tested for overexpression using Western blot analysis 
(S. Z. et al., unpublished data). Based on their overexpression and 
representative morphology, the following clones were used in this 
study: vector-transfected cells, RHAMM Iv4-overexpressing clones 
(cDNA 5-lOT1/2 and cDNA-3T3), and a mutated RHAMM lv4 clone 
(MR-lOTM-4). 
For dominant negative transfections, C3 cells were stably 
transfected with the mutated RHAMM cDNAs as described above, 
except that the hygromycin gene was included in the pHp APr-I-neo 
vector. Cells were selected in hygromycin and geneticin (to maintain 
ras insert) and then cloned. Clones that exhibited a flattened morphol- 
ogy (45% of clones) were selected and then analyzed for overexpres- 
sion of RHAMM using a Western transblot assay. Three high express- 
ing clones were selected. 
RHAMM cDNA (Hardwick et al., 1992) was used as a PCR template 
to generate a 1.7 kb fragment containing the entire coding region 
(amino acids l-477) and 172 nt of 3’flanking sequence. The fragment 
was cloned in an antisense orientation into the pHb Apr-I-neo expres- 
sion vector (Gunning et al., 1987) and sequenced for confirmation. To 
produce stably transfected cell lines, we transfected lOTl/z fibroblasts 
using lipofectin with RHAMM antisense plasmid constructs according 
to the instructions of the manufacturer (GIBCO BRL). In brief, 1 x 
105 to 2 x IoSof the lOTl/z cells were seeded into 60 mm tissue culture 
dishes and cultured in growth medium containing DMEM and 10% 
fetal bovine serum. After reaching 50%-70% confluence, cells were 
transfected with 1 O-20 pg of RHAMM plasmid, selected in G418, and 
then cloned. Low production of RHAMM was detected by Western blot 
analysis and RI-PCR. 
Cell Lysie and lmmunoblot Analysis 
C3 cell cultures were exposed to HA (10 nglml; Hall et al., 1994) or 
control treatments for various time periods at 37OC and then placed 
on ice. Culture medium was removed, the plates were rinsed with cold 
PBS (2.7 mM KCI, 1 .I mM KH*PO,, 138 mM NaCI, 8.1 mM Na2HP04 
[pH 7.41) containing 250 pM sodium orthovanadate, and the cells were 
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lysed with ice cold RIPA lysis buffer (25 mM Tris [pfi 7.21, 0.1% SDS, 
1% Triton X-l 00.1% sodium dexoycholate, 0.15 M NaCI, 1 mM EDTA) 
containing 10 uglml leupeptin, 10 &ml aprotinin, 1 mM PMSF, and 
1 mM sodium orthovanadate (all chemicals from Sigma). Lysates were 
scraped into microcentrifuge tubes and after 10 min on ice were centri- 
fuged at 13,000 rpm for 15 min at 4OC (Heraus Biofuge 13, Baxter 
Diagnostics). Protein concentrations of the supernatants and BSA 
standards were determined using the DC protein assay (Bit-Red), 
and duplicate samples containing 20 ug of protein each along with 
prestained molecular weight markers (Sigma) were separated by 
SDS-PAGE (12% gel). The proteins on the gets were eitherelectropho- 
retically transferred to nitrocellulose membranes (Bio-Rad) or stained 
with Coomassie blue to check for equal loading. Additional protein- 
binding sites on the nitrocellulose membranes were blocked with 5% 
defatted milk in TBS (50 mM Tris-HCI [pH 7.41, 200 mM NaCI). and 
then the membranes were incubated with anti-phosphotyrosine MAb 
4610 (1 ug/ml [Upstate Biotechnology] in 1% defatted milk in TBS) 
or anti-RHAMM antibody (1:200; Yang et al., 1994) for 2 hr at room 
temperature on a rotator (Nutator, Becton Dickinson). The membranes 
were washed four times in 0.05% Tween 20 in TBS before incubation 
with peroxidawoonjugated goat anti-mouse secondary antibody (I:5000 
dilution in 1% milk and Tween 20 in TBS; Sigma) for 1 hr at room 
temperature. After washing, blotsweredeveloped using the ECLWest- 
ern blotting detection system (Amersham) according to the instructions 
of the manufacturer. To establish antibody specificity, we probed paral- 
lel blots with anti-phosphotyrosine that had been preincubated with 
200 pM phosphotyrosine (Sigma) for 1 hr. Likewise, anti-RHAMM anti- 
bodies were preincubated with 200 pg of RHAMM fusion protein before 
incubation with membranes as above. 
lmmunopreclpltatlon 
Cells were stimulated with HA and lysed as described above. Each 
sample (500 ug of protein) was incubated with anti-p125FU MAb (4 
&ml monoclonal anti-FAK; Transduction Laboratories) and rabbit 
anti-mouse IgG (10 &ml; Sigma) for 1 hr at 4OC by mixing end-over- 
end. To cause precipitation, we added 100 pl of protein G-agarose 
(GIBCO BRL) to each tube, and the samples were mixed end-over-end 
for another 30 min at 4OC. The beads were pelleted by brief centrifuga- 
tion at 13,OGJ rpm and washed three times with RIPA buffer. The 
proteins were released from the beads by boiling in Laemmli sample 
buffer and were then subjected to SDS-PAGE and anti-phosphotyro- 
sine immunoblotting as described above. To assess whether equal 
quantities of FAK were immunoprecipitated from control and treated 
samples, the blots were stripped and reprobed with purified anti-FAK 
antibody 2A7 (10 us/ml; a gift from J. T. Parsons). 
Immunofluoreecent Stalnlng 
Vector control ras-lOTH, MR-C3-4D, and MR-C3-5C fibroblasts were 
grown on untreated or fibronectin-coated glass coverslips for 24 hr. 
The cells were exposed to HA (10 @ml), anti-RHAMM, or control 
treatment for 1 min and 15 min. At the appropriate time periods, the 
media was aspirated, and the cells were rinsed with PBS and then 
fixed with 3% paraformaldehyde (Sigma) in PBS for 10 min. Cells were 
washed three times for 10 min with wash solution (10% FCS in PBS 
containing 0.02% sodium azide), permeabilixed with 0.2% Triton 
X-100 in PBS for 5 min, and washed three more times. The fixed cells 
were incubated at 37*C for 1 hr with anti-phosphotyrosine MAb 4610 
(5 @ml; Upstate Biotechnology), anti-vinculin MAb (1:50, Sigma), or 
appropriate IgG controls (Sigma) in wash solution. After being washed 
five times, coverslips were incubated with goat anti-mouse Cy3 
(1500; Jackson) for 3 hr. After washing, the coverslips were mounted 
onto glass slides using Fluoromount (BDH). Observations and photo- 
micrographs were obtained with a Zeiss Axiovert 35x fluorescent 
microscope using epifluorescence. 
Time-Lapse Clncmlcrogrephy 
To monitor random locomotion, we plated 6 x 10’ cells in 25 cm2 
tissue culture flasks 24 hr prior to measurement. Cell locomotion was 
quantified using an IM 35 inverted microscope (Zeiss), to which a video 
camera (Hamamatsu CCD) was attached. The cells were maintained 
at 37OC using a heated platform (TRZ 3700, Zeiss). Motility was mea- 
sured using image analysis (Image 1, Universal Imaging). This pro- 
gram allows quantitation of nuclear displacement in a sequence of 
digitalized images. 
Flow Cytometry 
Cells were harvested using Hanks’ balanced salt solution plus 20 mM 
HEPES, 0.05% sodium azide, and 2.0 mM EDTA for 5 min and were 
maintained at 4OC throughout the procedure. The cells were washed 
in the same solution except in the absence of EDTA and then incubated 
with anti-peptide (amino acids266-266)antiserum (15Odilution; Hard- 
wick et al., 1992) for 30 min. Following this, the cells were incubated 
with ftuoresceinconjugated goat anti-rabbit antiserum (1300 dilution; 
Sigma) for a further 30 min and were then fixed with 3% paraformalde 
hyde. The surface expression of RHAMM was studied using immune 
fluorescence flow cytometry. Normal IgG was used as a control at 
each timepoint analyzed. 
HA Blnding Aeeey 
Proteins were electrophoresed on 10% SDS-polyacrylamide gel and 
transbfotted onto a nitrocellulose membrane in a Tris-glycine buffer 
containing 25 mM Tris, 192 mM glycine, and 20% methanol (pH 6.3) 
at 60 V for 1 hr in a cold room. The membrane was blocked in IO mM 
Tris-HCI (pH 6.0) containing 150 mM NaCl (TBS), 0.05% Tween 20 
(TBST), and 5% skim milk powder (TBSTS) for 1 hr at room tempera- 
ture and then incubated with biotinylated HA (Yang et al., 1994) and 
diluted in TBSTS (12000) overnight at 4OC. The membrane was 
washed with TBST extensively and then incubated with astreptavidin- 
peroxidase conjugate in TBSTS. Binding was visualized with chemilu- 
minescence according to the instructions of the kit (ECL Kit, Amer- 
sham), which uses luminal and hydrogen peroxide to visualize the 
bound peroxidase. 
Focus Formatlon 
Cells were grown to 50% confluence and, in the case of RHAMM 
antisense-transfected clones, transfected with H-ras using lipofectin 
as described above or, in the case of RHAMM sense-transfected 
clones, buffer only. The cultures were then grown for 3-4 weeks in 
DMEM medium containing lo%-20% FBS. The medium waschanged 
every 1-3 days for up to 4 weeks until foci formed. Foci were visualized 
with methylene blue staining and were counted per dish. 
Growth In Soft Agar 
We plated 5 x 1 OS cells per milliliter in bactoagar (1.25%) containing 
anti-MEM, 10% FBS for 7-10 days. Colonies of cells were counted 
per plate. The plating efficiency of each cell line was similar (75%). 
Subcutaneous Tumor Formetion and Tall Vein Aeeay 
Cells were grown to confluence, washed with Hanks’ solution and 
released from the substratum in Hanks solution containing 2.5 mM 
EDTA. If cells did not release (i.e., lOTI,+ cells), they were scraped 
from the substratum with a rubber poficeman. Excfusion of trypan blue 
indiceted that >90% of cells treated in this manner were viable. C3 
femalemicewereinjectedwith 1 x 10105 x 1Oceflssubcutaneousty 
into the right hind leg and maintained for 3-6 weeks, when tumors 
routinely become apparent. Animals were euthanized, tumors were 
removed and weighed, and pieces were processed for histology using 
paraffin embedding techniques. Lungs were also excised and exam- 
ined for tumor nodules, which, when present, were also processed 
for paraffin sections. 
For experimental metastasis assays (Egan et al., 1967), 5 x Iv 
cells were injected into the tail vein. The mice were maintained for 6 
weeks and then euthanized, lungs were removed, and the occurrence 
of tumor nodules was 859898Bd by processing tissue for histology and 
examining tissue sections for tumor nodules. 
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